Neumora Therapeutics, Inc. Conversion of Stock, Amount Converted
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountConverted1 · last filed 2025-03-03
- Neumora Therapeutics, Inc. conversion of stock, amount converted for the quarter ending 2023-12-31 was $0.00.
- Neumora Therapeutics, Inc. conversion of stock, amount converted for fiscal 2023 was $843.69M.
| Period end | Conversion of Stock, Amount Converted 3 month | Conversion of Stock, Amount Converted 9 month | Conversion of Stock, Amount Converted 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $843.69M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $843.69M 10-Q · filed 2024-11-12 |